StockGlow

Inovio Pharmaceuticals, Inc. (INO.MX)

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.

11.20-0.03%Healthcare
Compare INO.MX with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-58.5%

The outlook

Inovio Pharmaceuticals, Inc. currently reads as bearish based on below its 50- & 200-day averages, 0% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$921.5M
52-wk high
57.00
52-wk low
11.20
50-day avg
20.36
200-day avg
29.16
Trailing P/E
—

Similar stocks

PFE.MXPfizer Inc.$432.00+0.23%AAL.MXAmerican Airlines Group Inc.$265.32+0.45%MRNA.MXModerna, Inc.$969.00-3.01%NION.MXNIO Inc.$84.15+0.07%ZM.MXZoom Communications, Inc.$1,585.00+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy